Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Directorate Changes

26 Jul 2017 10:02

RNS Number : 1398M
Johnson Matthey PLC
26 July 2017
 

Johnson Matthey Plc Directorate Changes

 

The board of Johnson Matthey Plc is pleased to announce the appointment of John O'Higgins, as a non-executive director of the company. He will join the board with effect from 16th November 2017.

 

John is currently Chief Executive of Spectris plc, a leading supplier of productivity-enhancing instrumentation and controls. He joined the board of Spectris plc as Chief Executive in January 2006. Prior to this John worked for Honeywell in a number of management roles, including as president of automation and control solutions, Asia Pacific. He began his career as a design engineer at Daimler-Benz in Stuttgart.

 

John will be replacing Colin Matthews CBE FREng, a non-executive director and Chairman of the Remuneration Committee. Colin is standing down from his role with effect from 15th November 2017 after five years on the board, having been appointed a non-executive director in October 2012 and Chairman of the Remuneration Committee in July 2016.

 

Chris Mottershead, a non-executive director, will be appointed as Chairman of the Remuneration Committee from 16th November 2017.

 

Tim Stevenson OBE, Chairman, commented:

 

"On behalf of all of us on the board I would like to thank Colin for his significant contributions during his time as a non-executive director.

 

I am very pleased to welcome John to the board and we look forward to working with him and benefiting from his extensive business and industrial experience".

 

 

Disclosures required pursuant to Rule 9.6.13 of the Listing Rules of the Financial Conduct Authority (including directorships held in other publicly quoted companies at any time in the previous five years)

 

John was appointed as a director of Spectris plc in January 2006, a company listed on the London Stock Exchange.

 

From September 2010 to April 2015, John was a non-executive director of Exide Technologies, Inc, a company listed on the Nasdaq stock exchange.

 

Other than as stated in this announcement, there are no other disclosures required pursuant to Rule 9.6.13 of the Listing Rules of the Financial Conduct Authority.

 

Enquiries:

Sally Jones

Director of Corporate Communications

020 7269 8407

Andrew Grant/David Allchurch

Tulchan Communications

020 7353 4200

www.matthey.com

26th July 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUGUMUPMUBQ
Date   Source Headline
1st Jul 20247:00 amRNSDirectorate Change
27th Jun 20245:54 pmRNSHolding(s) in Company
27th Jun 202412:03 pmRNSHolding(s) in Company
27th Jun 20247:00 amRNSJohnson Matthey: PGM Services seminar
25th Jun 202410:35 amRNSHolding(s) in Company
20th Jun 202412:24 pmRNSDirector/PDMR Shareholding
14th Jun 20243:00 pmRNSHolding(s) in Company
6th Jun 20249:00 amRNSAnnual Financial Report
28th May 202410:13 amRNSHolding(s) in Company
23rd May 20247:00 amRNSJohnson Matthey Full Year Results
21st May 20245:04 pmRNSHolding(s) in Company
20th May 20245:04 pmRNSHolding(s) in Company
16th May 20244:43 pmRNSDirector/PDMR Shareholding
16th May 20244:11 pmRNSHolding(s) in Company
14th May 202412:05 pmRNSHolding(s) in Company
3rd May 20243:31 pmRNSHolding(s) in Company
2nd May 20249:00 amRNSHolding(s) in Company
22nd Apr 20243:39 pmRNSHolding(s) in Company
18th Apr 20245:33 pmRNSDirector/PDMR Shareholding
17th Apr 20243:07 pmRNSHolding(s) in Company
10th Apr 20243:10 pmRNSHolding(s) in Company
10th Apr 20249:47 amRNSHolding(s) in Company
9th Apr 20249:00 amRNSHolding(s) in Company
8th Apr 20249:00 amRNSHolding(s) in Company
3rd Apr 20245:16 pmRNSHolding(s) in Company
2nd Apr 20249:01 amRNSHolding(s) in Company
2nd Apr 20249:00 amRNSHolding(s) in Company
27th Mar 20241:46 pmRNSHolding(s) in Company
22nd Mar 20243:11 pmRNSHolding(s) in Company
21st Mar 202412:13 pmRNSDirector/PDMR Shareholding
20th Mar 20247:00 amRNSJohnson Matthey sale of Medical Device Components
18th Mar 20243:05 pmRNSHolding(s) in Company
18th Mar 20242:32 pmRNSHolding(s) in Company
12th Mar 20245:12 pmRNSHolding(s) in Company
12th Mar 20249:00 amRNSHolding(s) in Company
11th Mar 20249:00 amRNSHolding(s) in Company
7th Mar 20244:20 pmRNSHolding(s) in Company
22nd Feb 20244:53 pmRNSDirector/PDMR Shareholding
20th Feb 20243:57 pmRNSHolding(s) in Company
19th Feb 20243:12 pmRNSHolding(s) in Company
15th Feb 20249:54 amRNSDirector/PDMR Shareholding
9th Feb 20244:17 pmRNSHolding(s) in Company
9th Feb 202412:31 pmRNSDirector/PDMR Shareholding
8th Feb 20242:17 pmRNSHolding(s) in Company
1st Feb 20244:08 pmRNSHolding(s) in Company
29th Jan 20243:22 pmRNSHolding(s) in Company
29th Jan 20242:37 pmRNSHolding(s) in Company
29th Jan 20242:35 pmRNSHolding(s) in Company
23rd Jan 20244:47 pmRNSHolding(s) in Company
19th Jan 20242:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.